Literature DB >> 12657235

Patterns of failure following curative resection of colorectal liver metastases.

B Topal1, L Kaufman, R Aerts, F Penninckx.   

Abstract

AIMS: Several studies have focused on factors determining recurrence and survival rate after curative resection of colorectal liver metastases (LM). Data are lacking with regard to patterns of failure indicating where and when recurrences arise.
METHODS: One-hundred-and-five consecutive patients [F/M: 31/74; mean age 61 years (range 36-80 y)] with primary colorectal liver metastases underwent surgical R0 curative resection between 1990-1999. Patient follow-up was closed in January 2002. The common closing date method was used for survival analysis. Multivariate analysis was performed with the Cox proportional hazard technique.
RESULTS: The overall (OS) vs disease free survival (DFS) rates at 1, 2, and 5 years were 88.5 vs 63.3, 73.4 vs 40.2, and 36.8 vs 18.1%, respectively. Elevated serum CEA level was the only factor independently related to recurrent disease. Elevated serum CEA level, maximum diameter of liver metastases (LM), and satellitosis were factors significantly related to poor OS. Recurrent liver metastases developed in 43% and extra-hepatic metastases in 60% of the patients. In about half of the patients cancer recurrence was observed within 18 months, almost equally distributed between hepatic and extra-hepatic sites.
CONCLUSION: Despite optimal patient selection and curative resection of colorectal liver metastases, more than a half of the patients developed cancer recurrence within 2 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657235     DOI: 10.1053/ejso.2002.1421

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  16 in total

1.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.

Authors:  Elie Oussoultzoglou; Philippe Bachellier; Edoardo Rosso; Radu Scurtu; Ioan Lucescu; Michel Greget; Daniel Jaeck
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 3.  Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.

Authors:  Alice Zervoudakis; Taryn Boucher; Nancy E Kemeny
Journal:  Visc Med       Date:  2017-02-03

4.  Patients with multiple synchronous colonic cancer hepatic metastases benefit from enrolment in a "liver first" approach protocol.

Authors:  Dimitrios Kardassis; Achilleas Ntinas; Dimosthenis Miliaras; Alexandros Kofokotsios; Konstantinos Papazisis; Dionisios Vrochides
Journal:  World J Hepatol       Date:  2014-07-27

5.  Radio-frequency ablation of colorectal liver metastases in 167 patients.

Authors:  A R Gillams; W R Lees
Journal:  Eur Radiol       Date:  2004-07-27       Impact factor: 5.315

Review 6.  Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials.

Authors:  Peng Wang; Zhen Chen; Wen-Xia Huang; Lu-Ming Liu
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

7.  Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases.

Authors:  Yo-ichi Yamashita; Eisuke Adachi; Yasushi Toh; Kippei Ohgaki; Osamu Ikeda; Eiji Oki; Kazuhito Minami; Yoshihisa Sakaguchi; Eiji Tsujita; Takeshi Okamura
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

8.  Laparoscopic liver resection using radiofrequency coagulation.

Authors:  D Hompes; R Aerts; F Penninckx; B Topal
Journal:  Surg Endosc       Date:  2006-11-21       Impact factor: 4.584

9.  Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations.

Authors:  Ioannis Vassiliou; Nick Arkadopoulos; Theodosios Theodosopoulos; Georgios Fragulidis; Athanasios Marinis; Agathi Kondi-Paphiti; Lazaros Samanides; Andreas Polydorou; Constantinos Gennatas; Dionysios Voros; Vassilios Smyrniotis
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

10.  Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.

Authors:  Steven R Alberts; Mark S Roh; Michelle R Mahoney; Michael J O'Connell; David M Nagorney; Lawrence Wagman; Thomas C Smyrk; Timothy L Weiland; Lily Lau Lai; Roderich E Schwarz; Roy Molina; Todor Dentchev; John S Bolton
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.